4.6 Letter

Antibody response to 2-dose SARS-CoV-2 mRNA vaccination in pediatric solid organ transplant recipients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

Ayelet Grupper et al.

Summary: Only 37.5% of transplant recipients developed a positive immune response to the Pfizer vaccine, with lower antibody levels, and factors associated with null immune response include older age, high-dose corticosteroids use, triple immunosuppression maintenance, and regimen with mycophenolate.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Surgery

SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know

Maddalena Giannella et al.

Summary: SARS-CoV-2 vaccines provide important protection for SOT recipients, but antibody responses are decreased, and risk factors affecting immunogenicity should be noted, along with the need to continue personal protective measures. Prioritization of household contacts for vaccination after receiving the vaccine is recommended, while further research is needed for the evaluation of immune responses.

TRANSPLANT INTERNATIONAL (2021)

Article Microbiology

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers

Eshan U. Patel et al.

Summary: Accurate serological assays are crucial for detecting SARS-CoV-2 antibodies, but commercial EIAs may not always accurately detect high nAb titers in individuals, indicating the limitations of current diagnostic methods for COVID-19 convalescent plasma donation.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)